Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Treatment-Responsive Polymyositis Transforming into Inclusion Body Myositis
Muscle Disease/Neuromuscular Junction
(-)
019
Authors/Disclosures
Ashok Verma, MD, FÂ鶹´«Ã½Ó³»­ (University of Miami, Clinical Research Bldg) Dr. Verma has nothing to disclose.
Walter G. Bradley, DM, FRCP, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Cleanthe Spanaki, MD, PhD (Greece) The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PHARMABIDE/SPECIFAR-TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALLERGAN. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK SERONO. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ITF. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. The institution of Dr. Spanaki has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SPECIFAR/TEVA. The institution of Dr. Spanaki has received research support from ABBVIE.
Steven P. Ringel, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file